through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Introduction Asthma, allergic rhinitis, and chronic sinusitis are among the most common respiratory conditions worldwide. For decades, physicians have recognized that these conditions frequently occur together — but only more recent...
Exciting News! We're heading to ERS Congress 2026 in Barcelona! 🇪🇸 We are thrilled to announce that Yiliankang and UBreath® will be exhibiting at the European Respiratory Society (ERS) Congress 2026 from September 5–9 at F...
Introduction Pulmonary function tests (PFTs), also known as lung function tests, are a group of noninvasive breathing tests that measure how well your lungs are working. These tests evaluate three key aspects of respiratory function: how ...
Please complete the form to contact our team